HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contrast Media

Substances used to allow enhanced visualization of tissues.
Also Known As:
Contrast Agent; Contrast Agents; Contrast Material; Contrast Materials; Radiocontrast Agent; Radiocontrast Agents; Radiocontrast Media; Agent, Contrast; Agent, Radiocontrast; Agents, Contrast; Agents, Radiocontrast; Material, Contrast; Materials, Contrast; Media, Contrast; Media, Radiocontrast; Media, Radiopaque; Radiopaque Media
Networked: 14511 relevant articles (591 outcomes, 1550 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lu, Zheng-Rong: 47 articles (10/2022 - 01/2006)
2. Corot, Claire: 35 articles (01/2020 - 06/2002)
3. Shi, Xiangyang: 32 articles (06/2021 - 02/2012)
4. Fayad, Zahi A: 28 articles (06/2015 - 11/2004)
5. Singhal, Sunil: 26 articles (10/2022 - 11/2010)
6. Kang, Hye-Ryun: 25 articles (10/2022 - 11/2011)
7. Willmann, Jürgen K: 25 articles (01/2019 - 08/2002)
8. Naganawa, Shinji: 23 articles (07/2022 - 09/2008)
9. Chen, Xiaoyuan: 22 articles (01/2022 - 11/2004)
10. Hamm, Bernd: 22 articles (01/2021 - 04/2004)

Related Diseases

1. Neoplasms (Cancer)
01/01/2005 - "New and exciting research using highly specific and bright tumor-targeted fluorescence contrast agents is thrusting diagnostic endoscopy into a new era of "molecular endoscopy." Most studies reported to date have mainly focused on refining existing prototype instruments or continue on a basic research level, with the ultimate goal of improving sensitivity and specificity for colonic dysplasia, compared with the gold standard of histopathology. "
05/27/2022 - "Furthermore, advanced liver MRI techniques such as diffusion-weighted imaging and hepatobiliary contrast agents have improved the detection of focal liver lesions and can be highly effective in differentiating pseudotumor from tumors, as well as benign from malignant lesions, and can also be used for differential diagnosis. "
01/01/2013 - "The octapod iron oxide nanoparticles (edge length of 30 nm) exhibit an ultrahigh transverse relaxivity value (679.3 ± 30 mM(-1) s(-1)), indicating that these octapod iron oxide nanoparticles are much more effective T2 contrast agents for in vivo imaging and small tumour detection in comparison with conventional iron oxide nanoparticles, which holds great promise for highly sensitive, early stage and accurate detection of cancer in the clinic."
05/01/1994 - "It is concluded that iomeprol-200 and iopamidol-200 are safe and effective contrast media when used for carotid IA-DSA, an examination which proves useful not only for the diagnosis of vascular lesions, but also to best direct the management of patients scheduled for surgery of intracranial tumors."
06/14/2018 - "Functional MRI techniques, including diffusion-weighted imaging, MRI with hepatobiliary contrast agents, perfusion imaging, and magnetic resonance elastography, show promise in providing further important information regarding tumor biological behaviors. "
2. Neoplasm Metastasis (Metastasis)
3. Hepatocellular Carcinoma (Hepatoma)
05/01/2006 - "These results suggest there were more false-positive findings of contrast-enhanced lesions in cirrhotic livers on hepatic arterial dominant phase images obtained after injection of contrast material at 5 mL/sec than on images obtained after injection at 3 mL/sec. In the detection of small hypervascular hepatocellular carcinoma in cirrhotic liver, the risk of false-positive findings of lesions on hepatic arterial dominant phase images is significantly greater with the higher injection rate (5 mL/sec) than with the medium rate (3 mL/sec)."
10/01/2011 - "Transcatheter arterial chemoembolization (TACE) is an effective treatment for unresectable hepatocellular carcinoma (HCC); however, large volumes of radiocontrast agents are used for TACE and may induce renal dysfunction. "
01/01/2003 - "Contrast material-enhanced Doppler or gray-scale harmonic ultrasonography (US) may help determine the completeness or long-term therapeutic efficacy of radio-frequency (RF) ablation of hepatocellular carcinoma (HCC). "
01/01/2019 - "To compare the efficacy of magnetic resonance imaging (MRI) with hepatobiliary agents (HBA-MRI) and MRI with extracellular contrast agents (ECA-MRI) for detection of recurrent hepatocellular carcinoma (HCC) after multiple treatments. "
12/01/2018 - "We intraindividually compared the efficacy of magnetic resonance imaging (MRI) with extracellular contrast agents (ECA-MRI) and MRI with hepatobiliary agents (HBA-MRI) for the diagnosis of hepatocellular carcinoma (HCC) using the Liver Imaging Reporting and Data System (LI-RADS). "
4. Hypersensitivity (Allergy)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Gadolinium
2. Gadolinium DTPA (Magnevist)
3. ferric oxide (iron oxide)
4. Iodine
5. Contrast Media
6. gadobenic acid (gadobenate dimeglumine)
7. Liposomes (Liposome)
8. Biomarkers (Surrogate Marker)
9. gadolinium ethoxybenzyl DTPA
10. ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)

Related Therapies and Procedures

1. Therapeutics
2. Microbubbles
3. Drug Therapy (Chemotherapy)
4. Intravenous Injections
5. Radiotherapy